← Back to Search

Behavioural Intervention

fMRI Neurofeedback for Depression

N/A
Waitlist Available
Led By Stephan Taylor, MD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Not taking any medication, prescription or non-prescription, with psychotropic effects (birth control medications allowed)
If a woman of child-bearing age, not pregnant or trying to become pregnant
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 40 minutes (during the second mri)
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new technique called real-time fMRI neurofeedback. It uses a special brain scan to show participants their brain activity as it happens. The goal is to help people learn to control their brain activity, which could be useful for managing mental health conditions like depression. The study starts with healthy participants to refine the technique. Real-time fMRI neurofeedback has been used to help individuals learn to control their brain activity, with applications in treating various neurological and psychiatric conditions.

Who is the study for?
This trial is for individuals with depression or healthy subjects willing to give informed consent. Participants should not be on any psychotropic medications, except birth control. Women must not be pregnant or trying to conceive. Candidates must have no serious neurological illnesses, tolerate enclosed spaces without anxiety, and have no metal implants that could react in an MRI.
What is being tested?
The study is testing a technique called real-time fMRI neurofeedback which provides immediate feedback on brain activity while participants are in the scanner. The aim is to help people regulate their brain activity which may assist in managing symptoms of depression.
What are the potential side effects?
There are typically no direct side effects from undergoing an fMRI scan itself; however, some individuals might experience discomfort due to lying still for long periods or anxiety from being in the confined space of the MRI machine.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am not on any medication with mind-altering effects, except for birth control.
Select...
I am not pregnant nor trying to conceive.
Select...
I have no serious brain-related health issues or conditions like liver failure that could affect my brain.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 40 minutes (during the second mri)
This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 40 minutes (during the second mri) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Neurofeedback signal (moving window for each stop>recall trial pair) during the rtfMRI-NF session

Side effects data

From 2022 Phase 2 trial • 182 Patients • NCT02966873
19%
Gastrointestinal Discomfort
16%
Viral Upper Respiratory Tract Infections (Cold)
10%
Nausea
10%
Injury
9%
Muscle or Joint Pain
5%
Flatulence
4%
Headache/Migraine
3%
Sinusitis
2%
Pneumonia
2%
Anxiety
2%
Constipation
1%
Stroke
1%
Sepsis
1%
Pancreatitis
1%
Bladder Infection
1%
Injury/Accident
100%
80%
60%
40%
20%
0%
Study treatment Arm
N-Acetylcysteine (NAC) Treatment Group
Placebo Group

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Magnetic resonance imaging (MRI) groupExperimental Treatment1 Intervention
Healthy volunteers will have two functional magnetic resonance imaging scans (localizer session and the real time functional magnetic resonance imaging neurofeedback session).

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Real-time fMRI neurofeedback involves using functional MRI to monitor brain activity in real-time and providing feedback to the individual to help them regulate this activity. This technique targets specific brain regions associated with various cognitive and emotional functions. By receiving immediate feedback, individuals can learn to modulate their brain activity, potentially improving self-regulation and mental health. For healthy subjects, this matters because it can enhance cognitive performance, emotional regulation, and overall mental well-being, offering a non-invasive method to optimize brain function.
Psychotherapy and neuroscience: towards closer integration.

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,853 Previous Clinical Trials
6,433,005 Total Patients Enrolled
Stephan Taylor, MDPrincipal InvestigatorUniversity of Michigan
4 Previous Clinical Trials
359 Total Patients Enrolled

Media Library

Functional Magnetic Resonance Imaging (fMRI) (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05934604 — N/A
Healthy Subjects Research Study Groups: Magnetic resonance imaging (MRI) group
Healthy Subjects Clinical Trial 2023: Functional Magnetic Resonance Imaging (fMRI) Highlights & Side Effects. Trial Name: NCT05934604 — N/A
Functional Magnetic Resonance Imaging (fMRI) (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05934604 — N/A
~6 spots leftby Nov 2025